Evaxion announced successful preclinical results for EVX-04, an off-the-shelf therapeutic vaccine designed to treat acute myeloid leukemia (AML). The vaccine, developed using AI-Immunology™, targets specific tumor antigens and has shown effective immune activation and tumor cell killing in both human cells and animal models. These findings highlight EVX-04's potential to improve treatment options for AML patients, especially those ineligible for intensive therapies. Evaxion is preparing for clinical trials and will present detailed data at the European Hematology Association Congress in June 2026.
UniFirst shareholders overwhelmingly approved the company's acquisition by Cintas, with over 99% of votes in favor, representing about 95% of all shares. Under the deal, UniFirst shareholders will receive $155 in cash plus 0.7720 shares of Cintas sto...
Sanoma has formed its shareholders' Nomination Committee with four members representing its largest shareholders as of May 31, 2026. The committee, chaired by Juhani Mäkinen, will prepare proposals regarding the number, selection, and remuneration of...
American Gold & Copper Inc. (formerly Everlert, Inc.) is in preliminary talks to acquire a 100% interest in the Rimrock copper-gold project in Nevada's Battle Mountain Mining District. The project covers about 4,000 acres and shows significant geolog...
Sanoma Corporation has appointed four members to its Shareholders’ Nomination Committee, representing the company’s four largest shareholders as of May 31, 2026. Juhani Mäkinen was elected Chair of the Committee, which is responsible for proposing th...
Independent Bank Corporation (IBCP) has received regulatory approvals from the Federal Reserve Bank of Chicago and Michigan Department of Insurance and Financial Services to acquire HCB Financial Corp., the parent company of Highpoint Community Bank....
